BioMed Research International / 2010 / Article / Fig 2

Research Article

BALB/c Mice Vaccinated with Leishmania major Ribosomal Proteins Extracts Combined with CpG Oligodeoxynucleotides Become Resistant to Disease Caused by a Secondary Parasite Challenge

Figure 2

(a) Course of L. major  infection in protected and reinfected BALB/c mice. Values represent the mean lesion diameter±standard deviation (SD). * 𝑃 < . 0 0 1 : significant differences in inflammation for protected versus control mice at week seven postchallenge. (b) Seven weeks after reinfection, mice were euthanized and parasite burden in the ear dermis, spleen and in the retromaxillar DLN was individually quantitated. Results are expressed as the mean±SD of twelve ears and six spleens and DLN. * 𝑃 < . 0 0 1 : significant decrease for reinfected versus control mice. (c) The parasite burden at week seven after rechallenge was individually quantitated in the popliteal lymph nodes of control and reinfected mice. Results are expressed as the mean±SD of six DLN. * 𝑃 < . 0 0 1 : significant decrease for reinfected versus control mice.
181690.fig.002a
(a)
181690.fig.002b
(b)
181690.fig.002c
(c)

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.